Waddell & Associates LLC purchased a new position in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 4,092 shares of the biopharmaceutical company’s stock, valued at approximately $250,000. Several other hedge funds and other [...]
4,092 Shares in Bristol Myers Squibb Company (NYSE:BMY) Bought by Waddell & Associates LLC
